Specifically, in vitro, pretreatment with MLA (50 μM) or MEM (50 μM) significantly attenuated the survival rates of HBMECs and reduced the expression of inflammatory cytokines (such as IL-6 and TNF-α) after E. coli infection. This evidence concerns the gene TNF and escherichia coli infection.